Skip to main content
Caplight Logo









Meticuly

Meticuly

Private
BangkokHealthcare & Life Scienceshttps://www.meticuly.com/

Last Round

Series B

Nov 2, 2021

Total Funding Raised

$7.16M

Company Overview

Meticuly is a health tech company that develops and manufactures AI-powered, 3D-printed, patient-specific medical implants.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

patient-specific implants3D-printed implantsbone implantstitanium implantspoint of care manufacturingAI-assisted designmedical imaging AIprecision medicinecranio-maxillofacial implantsadditive manufacturingFactory-in-a-Boxorthopedic implantssurgical planning softwaremedical device manufacturingFDA 510(k) clearance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Meticuly Comparables

Compare Meticuly with similar companies based on industry and business-model similarity.

Meticuly comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ossiform
81%
Xilloc Medical B.V.
80%
Osteopore Ltd
73%

Meticuly Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 2, 2021
Series AOct 8, 2019
AcceleratorMar 30, 2018

Key People

Founding team and executive leadership

Boonrat L.

Chief Executive Officer

Executive Team

Sumate Chaisoorayakan

Chief Strategy Officer (CSO), Chief Financial Officer

Executive Team

Meticuly Investors

Notable investors and investment history

Meticuly investors
InvestorRounds
ExparaSeries B, Series A
Digital Ventures Company LimitedSeries A
BE Health VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 7, 2025

    Monthly visitors grew 301% MoM, reaching 1.2K.

  • Jun 1, 2025

    Monthly visitors grew 64% MoM, reaching 1.8K.

Meticuly Filings

Explore SEC and related filing metadata, where available.

Meticuly filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Meticuly's valuation, stock price, and market status.

Is Meticuly a public or private company?

Meticuly is a private company.

What is the current stock price of Meticuly?

Meticuly is a private company with no public stock price. No recent secondary market data is available.

How much is Meticuly worth (valuation)?

Valuation information for Meticuly is not publicly available.

Can I buy Meticuly stock?

Meticuly shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Meticuly's last funding round?

Meticuly's most recent funding round was Series B on November 2, 2021.

Who are the main investors in Meticuly?

Key investors in Meticuly include Expara, Digital Ventures Company Limited, BE Health Ventures.

Will Meticuly IPO soon?

No public IPO plans have been announced for Meticuly.

How can I track Meticuly secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Meticuly's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBangkok
Employee Range54
Year Founded2017
Last FundingNov 2, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?